142 related articles for article (PubMed ID: 27607353)
1. Mediastinal and Disseminated Mycobacterium kansasii Disease in GATA2 Deficiency.
Lovell JP; Zerbe CS; Olivier KN; Claypool RJ; Frein C; Anderson VL; Freeman AF; Holland SM
Ann Am Thorac Soc; 2016 Dec; 13(12):2169-2173. PubMed ID: 27607353
[TBL] [Abstract][Full Text] [Related]
2. GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report.
Mendes-de-Almeida DP; Andrade FG; Borges G; Dos Santos-Bueno FV; Vieira IF; da Rocha LKMDS; Mendes-da-Cruz DA; Zancopé-Oliveira RM; Calado RT; Pombo-de-Oliveira MS
BMC Med Genet; 2019 Apr; 20(1):64. PubMed ID: 31035956
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium kansasii.
Johnston JC; Chiang L; Elwood K
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
[TBL] [Abstract][Full Text] [Related]
4. Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.
Han SH; Kim KM; Chin BS; Choi SH; Lee HS; Kim MS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Kim JM
J Korean Med Sci; 2010 Feb; 25(2):304-8. PubMed ID: 20119588
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Disseminated
Kashihara E; Fujita K; Uchida N; Yamamoto Y; Mio T; Koyama H
Am J Trop Med Hyg; 2019 Nov; 101(5):1066-1069. PubMed ID: 31549614
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium kansasii and human immunodeficiency virus co-infection in London.
Klein JL; Corbett EL; Slade PM; Miller RF; Coker RJ
J Infect; 1998 Nov; 37(3):252-9. PubMed ID: 9892529
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus.
Pintado V; Gómez-Mampaso E; Martín-Dávila P; Cobo J; Navas E; Quereda C; Fortún J; Guerrero A
Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):582-6. PubMed ID: 10517196
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.
Levine B; Chaisson RE
Ann Intern Med; 1991 May; 114(10):861-8. PubMed ID: 1673053
[TBL] [Abstract][Full Text] [Related]
9. Pathologic features of Mycobacterium kansasii infection in patients with acquired immunodeficiency syndrome.
Smith MB; Molina CP; Schnadig VJ; Boyars MC; Aronson JF
Arch Pathol Lab Med; 2003 May; 127(5):554-60. PubMed ID: 12708897
[TBL] [Abstract][Full Text] [Related]
10. Fatal aortic pseudoaneurysm from disseminated Mycobacterium kansasii infection: case report.
Ehsani L; Reddy SC; Mosunjac M; Kraft CS; Guarner J
Hum Pathol; 2015 Mar; 46(3):467-70. PubMed ID: 25537975
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
Saleem N; Saba R; Maddika S; Weinstein M
Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
[TBL] [Abstract][Full Text] [Related]
12. Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient.
Zhang M; Feng M; He JQ
Int J Infect Dis; 2017 Sep; 62():59-63. PubMed ID: 28712930
[TBL] [Abstract][Full Text] [Related]
13. Disseminated nontuberculous mycobacteriosis and fungemia after second delivery in a patient with MonoMAC syndrome/GATA2 mutation: a case report.
Haraguchi M; Harada N; Watanabe J; Yoshikawa H; Shirai Y; Komura M; Koyama M; Ito J; Tsukune Y; Horimoto Y; Hayashi T; Nagaoka T; Uekusa T; Takahashi K
BMC Infect Dis; 2021 May; 21(1):502. PubMed ID: 34051752
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1.
Witzig RS; Fazal BA; Mera RM; Mushatt DM; Dejace PM; Greer DL; Hyslop NE
Clin Infect Dis; 1995 Jul; 21(1):77-85. PubMed ID: 7578764
[TBL] [Abstract][Full Text] [Related]
15. Disseminated coinfection with Mycobacterium Avium complex and Mycobacterium Kansasii in a patient with idiopathic CD4
Somboonviboon D; Thongtaeparak W; Suntavaruk P; Nasomsong W
J Infect Chemother; 2023 Dec; 29(12):1167-1171. PubMed ID: 37562711
[TBL] [Abstract][Full Text] [Related]
16. Clinical and radiological features of Mycobacterium kansasii and other NTM infections.
Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D
Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium kansasii septicaemia in an AIDS patient complicated by acute respiratory distress syndrome and acute liver failure.
Shaaban H; Layne T; Sensakovic JW; Boghossian J
Int J STD AIDS; 2014 Feb; 25(2):152-4. PubMed ID: 23970643
[TBL] [Abstract][Full Text] [Related]
18. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome.
Shitrit D; Priess R; Peled N; Bishara G; Shlomi D; Kramer MR
Eur J Clin Microbiol Infect Dis; 2007 Oct; 26(10):679-84. PubMed ID: 17629758
[TBL] [Abstract][Full Text] [Related]
20. CD4+ cells play a limited role in murine lung infection with Mycobacterium kansasii.
Wieland CW; Florquin S; Pater JM; Weijer S; van der Poll T
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):167-73. PubMed ID: 16195537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
